ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 0496

Higher Values of Atherogenic Index of Plasma Are Correlated with Increased Cardiovascular Risk in Patients with Psoriatic Arthritis

Valeria Gonzalez-Gonzalez1, Iris Colunga2, Dionicio A. Galarza-Delgado2, José Ramón Azpiri-López2, Rosa Arvizu-Rivera3, Jesus Alberto Cardenas-De la Garza4, Victor Beltran5 and Angel Arias Peralta6, 1Universidad Autónoma de Nuevo León, Monterrey, Mexico, 2Hospital Universitario UANL, Monterrey, Mexico, 3Hospital Universitario "Dr. José Eleuterio Gonzalez", Escobedo, Mexico, 4Hospital Universitario "Dr. José Eleuterio González", San Nicolas, Mexico, 5Rheumatology Service Hospital Universitario "Dr. José Eleuterio González", Monterrey, Mexico, 6Medicine Faculty, Universidad Autonoma De Nuevo Leon, Monterrey, Mexico

Meeting: ACR Convergence 2023

Keywords: Cardiovascular, Measurement Instrument, Psoriatic arthritis, Spondyloarthropathies, Subclinical Cardiovascular Disease

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0483–0509) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster I: PsA

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The atherogenic index of plasma (AIP) is a predictor of atherosclerosis and coronary heart disease. In patients with systemic lupus erythematosus and rheumatoid arthritis, AIP is correlated with increased cardiovascular risk measured by Framingham’s risk score. The correlation between AIP and calculated cardiovascular risk has not been studied in PsA-patients. To evaluate the correlation between AIP and six cardiovascular risk scores in patients with PsA.

Methods: Cross-sectional study that included PsA-patients aged 40 to 75 years who fulfilled the 2006 Classification Criteria for PsA. Patients with previous cardiovascular disease were excluded. AIP was defined by log (TG/HDL-C) mg/dL, and levels ≥0.21 were considered as high AIP. Cardiovascular disease risk was evaluated using 6 algorithms: ACC/AHA 2013, FRS-Lipids, FRS-BMI, RRS, QRISK3, and SCORE2. The Kolmogorov-Smirnov test was performed to evaluate the distribution of variables. The correlation between the AIP and cardiovascular risk algorithms was assessed by Spearman’s correlation coefficient. A value of p≤0.05 was considered statistically significant.

Results: A total of 94 patients with PsA were included, mostly women (n=52, 55.3%), the mean age was 53 ± 11.2, the disease duration of PsA was 5.0 (2.0-10.0) years, and the median AIP of all patients included was 0.49 (0.35-0.67). The median of each algorithm was: FRS-BMI 15.0 (6.7-27.8), FRS-Lipids 7.4 (3.0-16.4), SCORE 1.0 (1.0-3.0), QRISK3 5.6 (2.4-12.5), RRS 3 (2.0-7.5) and ACC/AHA 2013 5.3 (2.1-14.5). The most prevalent cardiovascular risk factor was dyslipidemia (n= 41, 43.6%). All cardiovascular risk algorithms presented a high positive correlation between AIP levels and cardiovascular risk. The calculator with the highest correlation was ACC/AHA 2013 (rs=0.641, p=0.000). (Table 1 and Figure 1).

Conclusion: In patients with PsA, higher values of AIP are associated with increased cardiovascular risk irrespective of the algorithm used. High AIP values could identify patients who would benefit from a non-invasive evaluation for subclinical atherosclerosis.

Supporting image 1

Table 1. Correlations between cardiovascular risk algorithms and AIP.

Supporting image 2

Figure 1. Scatterplots of the correlations between cardiovascular risk algorithms and AIP.


Disclosures: V. Gonzalez-Gonzalez: None; I. Colunga: None; D. Galarza-Delgado: None; J. Azpiri-López: None; R. Arvizu-Rivera: None; J. Cardenas-De la Garza: None; V. Beltran: None; A. Arias Peralta: None.

To cite this abstract in AMA style:

Gonzalez-Gonzalez V, Colunga I, Galarza-Delgado D, Azpiri-López J, Arvizu-Rivera R, Cardenas-De la Garza J, Beltran V, Arias Peralta A. Higher Values of Atherogenic Index of Plasma Are Correlated with Increased Cardiovascular Risk in Patients with Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/higher-values-of-atherogenic-index-of-plasma-are-correlated-with-increased-cardiovascular-risk-in-patients-with-psoriatic-arthritis/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/higher-values-of-atherogenic-index-of-plasma-are-correlated-with-increased-cardiovascular-risk-in-patients-with-psoriatic-arthritis/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology